October 25, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Shimadzu Scientific Instruments, Cure Pharmaceutical Corp and CK Sciences Form a Strategic Alliance for R&D of Pharmaceutical Cannabis Products

Columbia, MD (October 25, 2017) — Shimadzu Scientific Instruments, the leading provider of cannabis testing instruments, announces it has signed a Memorandum of Understanding (MOU) with Cure Pharmaceutical Corp and CK Sciences. This collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guidelines.... Read more

October 24, 2017 Bio/Pharma/CRO Lab Top-10

Tufts Center for Drug Development Study Quantifies Multimillion-Dollar Benefits of Using Single-Source Pharma Drug Development and Manufacturing Model

Tufts Center for Drug Development Study Quantifies Multimillion-Dollar Benefits of Using Single-Source Pharma Drug Development and Manufacturing Model DURHAM, N.C., Oct. 24, 2017 /PRNewswire/ — A newly released modeling study conducted by The Tufts Center for the Study of Drug Development (CSDD) finds that sponsors who employ single-source outsourcing partners, versus a multivendor development and... Read more

October 17, 2017 Acad, Gov/Utilities Bio/Pharma/CRO Industrial

VWR and Scientist.com Collaborate to Create an End-to-End Online Research Solution

RADNOR, Pa., Oct. 17, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today announced its collaborating with Scientist.com, the leading global online marketplace for research services. VWR customers in the U.S. can now purchase thousands of custom products and research services through... Read more

October 12, 2017 Bio/Pharma/CRO Cell Analysis Tools PR/Corporate

BioTime, Inc. Announces Proposed Public Offering of Common Stock

ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 12, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced its intent to offer to sell shares of its common stock in an underwritten public offering. BioTime intends to grant the underwriters a 30-day option to purchase up to... Read more

October 12, 2017 Bio/Pharma/CRO

Avantor Opens New Korea Life Sciences Research and Applications Facility

New Avantor Korea Laboratory is focused on optimizing biopharmaceutical purification processes for customers in the rapidly expanding life sciences industry in South Korea Located near local pharmaceutical and biopharmaceutical research and production customers, the Avantor Korea Lab offers both in-house and field service applications development support. Center Valley, PA (USA) – October 12, 2017 –... Read more

October 11, 2017 Bio/Pharma/CRO Lab Top-10

MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration

Massachusetts Gov. Charlie Baker and company executive board members cut the ribbon on new Life Science Center – Burlington Company convenes scientific symposium with leaders in Genome Editing, eCommerce and Big Data New Life Science Center includes an M Lab™ Collaboration Center and region’s first BioReliance® Biodevelopment Center Burlington, Massachusetts, October 11, 2017 — MilliporeSigma today... Read more

October 10, 2017 Bio/Pharma/CRO Lab Top-10 M&A, Partnerships

Shimadzu Scientific Instruments, Inc. and VpH, a division of Vyripharm Biopharmaceuticals, Establish the Medical Botanical Center of Excellence at University of Houston Innovation Center

The First Comprehensive Botanical Testing Platform Will Ensure Quality Control/Quality Assurance, and Validation/Verification for Patient Safety and Drug Efficacy in Texas HOUSTON, Oct. 10, 2017 /PRNewswire/ — Shimadzu Instrumentation Corporation announces a collaboration with VpH, to establish the Medical Botanical Center of Excellence. The Center represents the first fully comprehensive pharmaceutical grade Medical Botanical Testing Platform in Texas. The... Read more

October 2, 2017 Bio/Pharma/CRO Microscopy Product Launch

HORIZON Particle Analysis Launches in Europe at MIBio 2017

  The HORIZON subvisible particle analysis system The HORIZON subvisible particle analysis system PHILADELPHIA, Oct. 2, 2017 /PRNewswire/ — Halo Labs announces the European launch of their new low volume, high throughput biopharmaceutical particle analysis system called the HORIZON at MIBio 2017 in Cambridge, U.K on October 4th. The new system analyzes subvisible and visible particulate matter in biopharmaceutical samples... Read more